Vol. 3, Issue 3 (2014)
Dyslipidemia and Heart Failure: The Analysis of 2-years Observation
Heart failure (HF) is important medical and social problem. The rate of new cases of heart failure is 10 per 1000 individuals aged over 65 years, 52.3% of all heart failure patients die within five years of their initial diagnosis. Lipid metabolism is modified risk factor of cardiovascular diseases. The aim of our study was to evaluate the dynamic of lipids metabolism in patients with HF. We observed of 35 patients with HF II-III FC (NYHA). Our results showed that nobody observed persons had target LDL-C level. Thus, the lipid-lowering strategy was imperfect in all observed patients with HF. This direction of therapy should be revised (active life-style modification, raising of statines doses or additional prescription other lipid-lowering medicaments).
How to cite this article:
Sergiy Fedorov. Dyslipidemia and Heart Failure: The Analysis of 2-years Observation. The Pharma Innovation Journal. 2014; 3(3): 09-12.